Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI News and commentary from the endocrinology world Aug 06, 2024
Prescription-Free Online Semaglutide Is Risky Business Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
Aerosmith Retires After Injury; All Zepbound Doses Now Available; Guacamole Recalled Health news and commentary gathered by staff Aug 05, 2024
Intermittent Fasting May Improve Memory, Executive Function, Early Trial Suggests Exploratory study lays groundwork for larger trials to evaluate brain health Aug 04, 2024
New Firearm Injury Numbers; Another Indication for Semaglutide? Also in TTHealthWatch: bilateral mastectomy for breast cancer Aug 03, 2024 podcast
Semaglutide May Help Smokers Quit, Study Suggests Use for diabetes tied to fewer medical visits for tobacco use disorder versus other antidiabetics Jul 30, 2024
Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushback News and commentary from the endocrinology world Jul 30, 2024
FDA Warns of Overdoses With Compounded Semaglutide Multi-dose vials pose complications for self-administration Jul 29, 2024
Maternal Obesity Linked to Sudden Unexpected Infant Death Researchers found a dose-dependent link but causal mechanism remains unclear Jul 29, 2024
Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues News and commentary from the endocrinology world Jul 23, 2024
People Without Diabetes Make Up Growing Share of GLP-1 Users Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down News and commentary from the endocrinology world Jul 16, 2024
We've Been Here Before: The Politicization of Drug Pricing Ensuring medication access does not have to come at the cost of innovation Jul 16, 2024
Shedding Criticisms: The Real Weight of Misunderstanding Obesity Stigma and misconceptions create barriers to medication uptake Jul 14, 2024
New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Banned News and commentary from the endocrinology world Jul 09, 2024
Tirzepatide Bests Semaglutide for Real-World Weight Loss Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers For people with diabetes, cancer risks were reduced with GLP-1s versus insulin Jul 05, 2024
More Data Link Obesity to Better Survival for Cancer Patients on Immunotherapy Higher BMI also associated with improvements in functional outcomes in this setting Jul 04, 2024
Semaglutide May Be Linked to Condition That Causes Blindness Association with optic neuropathy in observational data needs further study to assess causality Jul 03, 2024
House Panel OKs Bills on Obesity Drug and Breakthrough Device Coverage in Medicare Meanwhile, CMS proposed rule on the device coverage, issued a year ago, awaits a final version Jul 01, 2024
CAH Drug Under Review; Gender-Affirming Surgery in Kids; CGMs for Non-Diabetics News and commentary from the endocrinology world Jul 01, 2024
Many Kids Benefit From GLP-1s. What Happens When They Have to Stop Taking Them? Prepare patients early for a time when medication is no longer an option Jul 01, 2024
Adolescent Obesity Tied to Parents' BMI at the Same Age Moderate association between parental and offspring BMI at age 17 Jun 28, 2024
First GLP-1 Generic Launched; 5:2 Intermittent Fasting Win; WHO's Ozempic Warning News and commentary from the endocrinology world Jun 25, 2024
Major Heart Events Down With Metabolic Surgery for Apnea Patients With Obesity All-cause mortality also lower compared with nonsurgical controls Jun 24, 2024
Novel GLP-1/Glucagon Drug Promising for Weight Loss Phase II data support testing pemvidutide for comorbid obesity and liver conditions Jun 24, 2024
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D Insulin sensitivity also improved in people with obesity free of diabetes Jun 23, 2024
Tirzepatide May Help Treat Sleep Apnea in People With Obesity Zepbound met primary and secondary endpoints, with or without CPAP Jun 21, 2024
Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis Previous exposure to biologics, higher BMI, smoking all negatively linked to response Jun 18, 2024
Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss News and commentary from the endocrinology world Jun 18, 2024
USPSTF Recommends Behavioral Interventions for Kids With High BMI Final recommendations did not include weight-loss drugs Jun 18, 2024
For Teens With Severe Obesity, Financial Incentives Work for Weight Loss Randomized trial proves benefit of adding gift card incentives to dietary measures Jun 17, 2024
Two OTC CGMs Cleared; USPSTF Draft Recs for Osteoporosis; Generic Ozempic in Testing News and commentary from the endocrinology world Jun 11, 2024
Missing Doc Found Dead; Trump's False Insulin Claim; CDC's Bird Flu Study Health news and commentary gathered by staff Jun 10, 2024
Bariatric Surgery Linked With Lower Mortality vs GLP-1 Drugs in Study, but ... Analysis of patients with obesity and diabetes only looked at first-generation GLP-1 agonists Jun 07, 2024
Search for Missing Doctor; Energy Drinks and Sudden Death; Unusual Pandemic Cancers Health news and commentary gathered by staff Jun 07, 2024
ENDO 2024 Roundup: Teen GLP-1 Coverage; Novel CAH Drug; Hot Flash Risks More research from the Endocrine Society's annual meeting Jun 05, 2024
Chinese Herbs for Diabetes Prevention; Long-Term Tepezza Data; Novel Cushing's Tx News and commentary from the endocrinology world Jun 03, 2024